Mitochondrial calcium uniporter as biomarker and therapeutic target for breast cancer: Prognostication, immune microenvironment, epigenetic regulation and precision medicine
CONCLUSION: MCU shows significant implication in prognosis, outcome prediction, microenvironmental shaping and precision medicine for BC. miR-29a-mediated MCU inhibition exerts therapeutic effect in tumor growth and metastasis.PMID:38663838 | DOI:10.1016/j.jare.2024.04.015
Source: Cell Research - Category: Cytology Authors: Hung-Yu Lin Pei-Yi Chu Source Type: research
More News: Allergy & Immunology | Breast Cancer | Calcium | Cancer | Cancer & Oncology | Cytology | Databases & Libraries | Docetaxel | Genetics | Learning | Mitochondria | Study | Taxotere | Universities & Medical Training